Morgan Stanley Knock-Out Novo-Nor.../ DE000ME0TTW3 /
14/11/2024 20:30:26 | Var.-0.01 | Denaro22:00:39 | Lettera22:00:39 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
2.68EUR | -0.37% | - Quantità in denaro: - |
- Quantità in lettera: - |
- | 553.9836 DKK | 31/12/2078 | Call |
Newsfile Corp
28/08
The GLP-1 Products and Players - Expanding a new Era of Pharmaceutical Products for Diabetes and Wei...
GlobeNewswire
28/08
Hematologists Highlight Ongoing Challenges in Sickle Cell Disease and Thalassemia Amidst Promising A...
GlobeNewswire
28/08
Lemonaid Health Now Offering GLP-1 Medication Through Weight Loss Membership Program
GlobeNewswire
27/08
COSCIENS Biopharma Inc. Announces Top-Line Results of Phase 3 DETECT-Trial for the Diagnosis of Chil...
GlobeNewswire
26/08
Dewpoint Therapeutics Awarded Target ALS Grant for the Second Time for Development of c-mods for Amy...
GlobeNewswire
21/08
ProLynx announces preclinical results of long-acting semaglutide requiring once monthly dosing
GlobeNewswire
14/08
19th Annual Cardiometabolic Health Congress: Honoring the Life and Legacy of CMHC Co-Chair Dr. Georg...
GlobeNewswire
06/08
Lucrative Incentive for Biotechs as Global Alzheimer's Disease Therapeutics Market Forecasted to Rea...
GlobeNewswire
01/08
Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Dire...
GlobeNewswire
11/07
Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansio...
GlobeNewswire
11/07
NMD Pharma adds new capabilities with several senior recruits to support its growing business and pi...
GlobeNewswire
11/07
NMD Pharma adds new capabilities with several senior recruits to support its growing business and pi...